Drug Profile
Research programme: heat-activated liposome encapsulated cancer therapeutics - Imunon
Alternative Names: Liposomal carboplatin; Liposomal docetaxelLatest Information Update: 21 Sep 2022
Price :
$50
*
At a glance
- Originator Celsion Corporation
- Developer Duke University Medical Center; Imunon
- Class Platinum complexes; Small molecules; Taxanes
- Mechanism of Action DNA cross linking agents; DNA synthesis inhibitors; Tubulin inhibitors; Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Cancer